Andrew King

Andrew King

Company: Chinook Therapeutics

Job title: Head of Renal Discovery & Translational Medicine

Seminars:

Selective ETA receptor antagonist ATRASENTAN for the Treatment of Primary Glomerular Diseases 10:00 am

Read more

day: Day Two

Panel Discussion: Executing Precision Medicine in Clinical Trials 2:45 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.